HomeBUSINESS
BUSINESS

Sumitomo Dainippon to Slash Manufacturing Jobs via Another Voluntary Redundancy Program
(Sep.28.2017)

Sumitomo Dainippon Pharma said on September 27 that it will launch another voluntary redundancy program, this time covering manufacturing employees, as it faces slumping revenues from off-patent products and the US patent expiry of its flagship antipsychotic med Latuda (lurasidone) looming in January 2019 ...
(LOG IN FOR FULL STORY)

News Calendar